Cargando…

The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population

Background: Dyslipidemia is a common risk factor for premature myocardial infarction (PMI). Our previous work has shown that single-nucleotide polymorphisms (SNPs) of LDLR, APOB, and PCSK9 are associated with dyslipidemia, but how these SNPs correlate with risk for PMI is unknown. Objective: This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lincheng, Pu, Tian, Zhang, Yan, Yan, Hua, Yu, Haiyi, Gao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035790/
https://www.ncbi.nlm.nih.gov/pubmed/35480303
http://dx.doi.org/10.3389/fgene.2022.875269
_version_ 1784693375754043392
author Yang, Lincheng
Pu, Tian
Zhang, Yan
Yan, Hua
Yu, Haiyi
Gao, Wei
author_facet Yang, Lincheng
Pu, Tian
Zhang, Yan
Yan, Hua
Yu, Haiyi
Gao, Wei
author_sort Yang, Lincheng
collection PubMed
description Background: Dyslipidemia is a common risk factor for premature myocardial infarction (PMI). Our previous work has shown that single-nucleotide polymorphisms (SNPs) of LDLR, APOB, and PCSK9 are associated with dyslipidemia, but how these SNPs correlate with risk for PMI is unknown. Objective: This study aims to evaluate the association between SNPs of LDLR, APOB, and PCSK9 and risk of PMI in Chinese Han population. Methods: Two cohorts were established. In Cohort 1 (413 in the PMI group and 1,239 in the control group), SNPs of APOB, LDLR, and PCSK9 with minor allele frequency (MAF) > 1%, which has been shown to impact the risk of PMI in a Chinese Han population, were thoroughly examined, and gene–environment interactions were analyzed. A model for PMI risk prediction was developed in Cohort 1 and externally validated in Cohort 2 (577 in the PMI group and 270 in the control group). Results: The distribution of the T allele at the PCSK9 R93C variant (rs151193009, C > T) was lower in the PMI group than that in the control group (PMI vs. Control in Cohort 1, 0.8% vs. 2.3%, P ( adjust ) < 0.05; in Cohort 2, 1.0% vs. 2.4%, P ( adjust ) < 0.05). The T allele at PCSK9 R93C variant (rs151193009, C > T) reduced the risk of PMI by ∼60% regardless of adjusting for confounding factors (in Cohort 1, adjusted odds ratio (OR) 0.354, 95% confidence interval (CI) 0.139–0.900, p = 0.029; in Cohort 2, adjusted OR 0.394, 95% CI 0.157–0.987, p = 0.047). No gene–environment interactions were observed between the R93C variant and diabetes/hypertension/smoking in PMI occurrence in this Chinese Han population. Our model showed good performance in predicting the risk of PMI in Cohort 1 (AUC 0.839, 95% CI 0.815–0.862, p < 0.001) and in an external cohort (AUC 0.840, 95% CI 0.810–0.871, p < 0.001). Conclusions: The PCSK9 R93C variant was associated with significantly reduced risk of PMI in the Chinese Han population, and the model we developed performed well in predicting PMI risk in this Chinese Han population.
format Online
Article
Text
id pubmed-9035790
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90357902022-04-26 The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population Yang, Lincheng Pu, Tian Zhang, Yan Yan, Hua Yu, Haiyi Gao, Wei Front Genet Genetics Background: Dyslipidemia is a common risk factor for premature myocardial infarction (PMI). Our previous work has shown that single-nucleotide polymorphisms (SNPs) of LDLR, APOB, and PCSK9 are associated with dyslipidemia, but how these SNPs correlate with risk for PMI is unknown. Objective: This study aims to evaluate the association between SNPs of LDLR, APOB, and PCSK9 and risk of PMI in Chinese Han population. Methods: Two cohorts were established. In Cohort 1 (413 in the PMI group and 1,239 in the control group), SNPs of APOB, LDLR, and PCSK9 with minor allele frequency (MAF) > 1%, which has been shown to impact the risk of PMI in a Chinese Han population, were thoroughly examined, and gene–environment interactions were analyzed. A model for PMI risk prediction was developed in Cohort 1 and externally validated in Cohort 2 (577 in the PMI group and 270 in the control group). Results: The distribution of the T allele at the PCSK9 R93C variant (rs151193009, C > T) was lower in the PMI group than that in the control group (PMI vs. Control in Cohort 1, 0.8% vs. 2.3%, P ( adjust ) < 0.05; in Cohort 2, 1.0% vs. 2.4%, P ( adjust ) < 0.05). The T allele at PCSK9 R93C variant (rs151193009, C > T) reduced the risk of PMI by ∼60% regardless of adjusting for confounding factors (in Cohort 1, adjusted odds ratio (OR) 0.354, 95% confidence interval (CI) 0.139–0.900, p = 0.029; in Cohort 2, adjusted OR 0.394, 95% CI 0.157–0.987, p = 0.047). No gene–environment interactions were observed between the R93C variant and diabetes/hypertension/smoking in PMI occurrence in this Chinese Han population. Our model showed good performance in predicting the risk of PMI in Cohort 1 (AUC 0.839, 95% CI 0.815–0.862, p < 0.001) and in an external cohort (AUC 0.840, 95% CI 0.810–0.871, p < 0.001). Conclusions: The PCSK9 R93C variant was associated with significantly reduced risk of PMI in the Chinese Han population, and the model we developed performed well in predicting PMI risk in this Chinese Han population. Frontiers Media S.A. 2022-04-11 /pmc/articles/PMC9035790/ /pubmed/35480303 http://dx.doi.org/10.3389/fgene.2022.875269 Text en Copyright © 2022 Yang, Pu, Zhang, Yan, Yu and Gao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Yang, Lincheng
Pu, Tian
Zhang, Yan
Yan, Hua
Yu, Haiyi
Gao, Wei
The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population
title The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population
title_full The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population
title_fullStr The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population
title_full_unstemmed The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population
title_short The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population
title_sort r93c variant of pcsk9 reduces the risk of premature mi in a chinese han population
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035790/
https://www.ncbi.nlm.nih.gov/pubmed/35480303
http://dx.doi.org/10.3389/fgene.2022.875269
work_keys_str_mv AT yanglincheng ther93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT putian ther93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT zhangyan ther93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT yanhua ther93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT yuhaiyi ther93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT gaowei ther93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT yanglincheng r93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT putian r93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT zhangyan r93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT yanhua r93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT yuhaiyi r93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation
AT gaowei r93cvariantofpcsk9reducestheriskofprematuremiinachinesehanpopulation